Selenoprotein P1 as a biomarker of insulin resistance in pediatric obesity: Insights and implications

doi:10.5409/wjcp.v14.i1.99652

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (169)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=97

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=55

Mar 9, 2025 (publication date) through Jan 1, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Pediatr. Mar 9, 2025; 14(1): 99652
Published online Mar 9, 2025. doi: 10.5409/wjcp.v14.i1.99652

Selenoprotein P1 as a biomarker of insulin resistance in pediatric obesity: Insights and implications

Chun-Han Cheng, Wen-Rui Hao, Tzu-Hurng Cheng

Chun-Han Cheng, Department of Medical Education, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan

Wen-Rui Hao, Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Ministry of Health and Welfare, Taipei Medical University, New Taipei 23561, Taiwan

Wen-Rui Hao, Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11002, Taiwan

Tzu-Hurng Cheng, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, Taichung 404328, Taiwan

Co-first authors: Chun-Han Cheng and Wen-Rui Hao.

Author contributions: The authors, Cheng CH, Hao WR, and Cheng TH, have contributed to this editorial, with Cheng CH and Hao WR primarily responsible for writing, and Cheng TH overseeing revisions. All authors have read and approved the final manuscript.

Conflict-of-interest statement: All authors declare having no conflicts of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Tzu-Hurng Cheng, PhD, Professor, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, No. 91 Xueshi Road, North District, Taichung 404328, Taiwan. thcheng@mail.cmu.edu.tw

Received: July 26, 2024
Revised: October 31, 2024
Accepted: November 12, 2024
Published online: March 9, 2025
Processing time: 146 Days and 9 Hours

Core Tip

Core Tip: This editorial discusses the findings of Elbarky et al that selenoprotein P1 (SEPP1) is a potential biomarker of insulin resistance in children with obesity. Their study suggests that lower SEPP1 levels are correlated with increased adiposity and insulin resistance, emphasizing the potential of SEPP1 to inform early detection and intervention strategies for pediatric metabolic disorders. Further research is necessary to validate these findings and explore the clinical applications of SEPP1.